Bevacizumab/ranibizumab: Ocular hypertension following intravitreal administration: 23 case reports

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1414, 2012-01, pp. : 15-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bevacizumab/ranibizumab: Ocular hypertension following intravitreal injection in elderly patients: 4 case reports

Reactions Weekly, Vol. 1, Iss. 1302, 2010-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Bevacizumab/ranibizumab: Subretinal fibrosis following intravitreal administration: 7 case reports

Reactions Weekly, Vol. 1, Iss. 1353, 2011-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Bevacizumab/ranibizumab: Intraocular inflammation following intravitreal administration: 4 case reports

Reactions Weekly, Vol. 1, Iss. 1330, 2010-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Bevacizumab/ranibizumab: Bacterial endophthalmitis and acute intraocular inflammation following intravitreal administration: 9 case reports

Reactions Weekly, Vol. 1, Iss. 1316, 2010-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Bevacizumab/ranibizumab: Elevation of intraocular pressure following intravitreal administration: 6 case reports

Reactions Weekly, Vol. 1, Iss. 1430, 2012-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite